← Leaderboards
Gabriel Lopez-Berestein
University Of Texas Md Anderson Can Ctr
$9,617,602
Attributed
$25,129,242
Total exposure
37
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.9M · FY2005–21$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$73,544,266 · 40
By mechanism
U54$62,438,460 · 33
UH3$3,158,668 · 1
RC2$3,001,830 · 1
U01$2,500,983 · 1
UH2$1,080,000 · 1
R21$760,381 · 2
Top collaborators
- Elizabeth L Travis115 shared
- David W Wetter100 shared
- Michelle Ann Barton99 shared
- Brad R Weiner99 shared
- Jose F Cordero97 shared
- Ruy Lopez Ridaura72 shared
- Marcia R Cruz Correa61 shared
- Reynold Eugenio Lopez-Enriquez45 shared
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Elizabeth L Travis$5,557,622
- Donald A Berry$14,634,533
Others in their field
Top investigators on “University Of Texas M D Anderson Cancer Center”
- David D McPherson · Northwestern University$40,585,186
- Robert C Bast · University Of Texas Md Anderson Can Ctr$20,938,578
- Daniel D Karp · Beth Israel Deaconess Medical Center$20,524,258
- Ziding Feng · Fred Hutchinson Cancer Research Center$17,268,474
- Stanley R Hamilton · Johns Hopkins University$17,257,683
- Richard A Gibbs · Baylor College Of Medicine$13,688,011
Research focus
University Of Texas M D Anderson Cancer CenterAnticancer ResearchMalignant NeoplasmsBasePuerto RicoGrantTrainingProgramsResearch Project GrantsCollaborationsFundingCancer Health DisparityResearch PersonnelTranslational ResearchFacultyDesignCancer CenterInterestOutreach ProgramResearch InfrastructureCareer DevelopmentFosteringHispanicsInnovation
Grant awards (162)
Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling$500,198
U01 · FY2021 · CA · contact PI
Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling$500,198
U01 · FY2020 · CA · contact PI
Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling$485,191
U01 · FY2019 · CA · contact PI
Outreach Core$300,000
U54 · FY2019 · CA
UPR/MDACC: Partnership for Excellence in Cancer Research$300,000
U54 · FY2019 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$679,977
U54 · FY2018 · CA
Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling$500,198
U01 · FY2018 · CA · contact PI
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$400,000
U54 · FY2018 · CA
Core-001$180,728
U54 · FY2018 · CA
Admin-Core-001$160,929
U54 · FY2018 · CA
Administrative Core$152,045
U54 · FY2018 · CA
Developmental Core$125,516
U54 · FY2018 · CA
Planning and Evaluation$84,439
U54 · FY2018 · CA
TCDC$81,962
U54 · FY2018 · CA
BEBiC$76,208
U54 · FY2018 · CA
Training Core$68,661
U54 · FY2018 · CA
Biostatistics, Epidemiology, and Bioinformatics Core (BEBiC)$27,432
U54 · FY2018 · CA
Pilot Project D$21,390
U54 · FY2018 · CA
Outreach Core$21,344
U54 · FY2018 · CA
PEC$20,566
U54 · FY2018 · CA
Education Core$19,812
U54 · FY2018 · CA
Core-005$19,673
U54 · FY2018 · CA
Pilot Project F$15,288
U54 · FY2018 · CA
Core-007$3,984
U54 · FY2018 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$1,391,697
U54 · FY2017 · CA
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$1,000,000
UH3 · FY2017 · TR
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$871,799
U54 · FY2017 · CA
Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling$515,198
U01 · FY2017 · CA · contact PI
Developmental Core$394,012
U54 · FY2017 · CA
Outreach Core$268,378
U54 · FY2017 · CA
Administrative Core$263,966
U54 · FY2017 · CA
Overall Objectives and ADM$214,486
U54 · FY2017 · CA · contact PI
Cancer Education Core: Curriculum in Cancer Medicine, Science, and Health Disparities$178,880
U54 · FY2017 · CA · contact PI
Biostatistics, Epidemiology, and Bioinformatics Core (BEBiC)$169,627
U54 · FY2017 · CA
Planning and Evaluation$161,520
U54 · FY2017 · CA
Training Core$112,836
U54 · FY2017 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$72,364
U54 · FY2017 · CA · contact PI
Education Core$69,417
U54 · FY2017 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$1,467,170
U54 · FY2016 · CA
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$1,000,000
UH3 · FY2016 · TR
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$931,644
U54 · FY2016 · CA · contact PI
Developmental Core$384,553
U54 · FY2016 · CA
Outreach Core$301,499
U54 · FY2016 · CA
Administrative Core$263,966
U54 · FY2016 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$217,227
U54 · FY2016 · CA
Targeting Kras in Pancreatic Cancer$208,800
R21 · FY2016 · CA
Biostatistics, Epidemiology, and Bioinformatics Core (BEBiC)$169,627
U54 · FY2016 · CA
Planning and Evaluation$164,431
U54 · FY2016 · CA
Training Core$112,837
U54 · FY2016 · CA
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$80,000
UH3 · FY2016 · TR
Overall Objectives and ADM$74,927
U54 · FY2016 · CA · contact PI
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$72,364
U54 · FY2016 · CA · contact PI
Education Core$70,257
U54 · FY2016 · CA
Cancer Education Core: Curriculum in Cancer Medicine, Science, and Health Disparities$68,600
U54 · FY2016 · CA · contact PI
Planning and Evaluation Core$16,344
U54 · FY2016 · CA · contact PI
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$1,553,790
U54 · FY2015 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,056,847
U54 · FY2015 · CA · contact PI
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$999,500
UH3 · FY2015 · TR
Developmental Core$482,508
U54 · FY2015 · CA
Outreach Core$328,510
U54 · FY2015 · CA
Administrative Core$257,090
U54 · FY2015 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$198,411
U54 · FY2015 · CA
Overall Objectives and ADM$193,099
U54 · FY2015 · CA · contact PI
Targeting Kras in Pancreatic Cancer$174,000
R21 · FY2015 · CA
Biostatistics, Epidemiology, and Bioinformatics Core (BEBiC)$158,588
U54 · FY2015 · CA
UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297)$152,250
U54 · FY2015 · CA
Planning and Evaluation$150,437
U54 · FY2015 · CA
Training Core$110,767
U54 · FY2015 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$110,195
U54 · FY2015 · CA
Cancer Education Core: Curriculum in Cancer Medicine, Science, and Health Disparities$101,389
U54 · FY2015 · CA · contact PI
Planning and Evaluation Core$81,458
U54 · FY2015 · CA · contact PI
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$79,168
UH3 · FY2015 · TR
Education Core$65,890
U54 · FY2015 · CA
Texas Center for Cancer Nanomedicine$2,695,386
U54 · FY2014 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$1,499,199
U54 · FY2014 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,038,286
U54 · FY2014 · CA · contact PI
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$500,000
UH2 · FY2014 · TR
Developmental Core$475,944
U54 · FY2014 · CA
Multistage Vectors (MSV) for Ovarian Cancer Therapeutics$411,645
U54 · FY2014 · CA · contact PI
Outreach Core$274,750
U54 · FY2014 · CA
Administrative Core$260,760
U54 · FY2014 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$195,456
U54 · FY2014 · CA
Overall Objectives and ADM$191,481
U54 · FY2014 · CA · contact PI
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$170,000
U54 · FY2014 · CA
(PQD3) The role and therapeutic potential of ZNF304 in Ovarian Cancer$168,781
R21 · FY2014 · CA
Planning and Evaluation$159,252
U54 · FY2014 · CA
Biostatistics, Epidemiology, and Bioinformatics Core (BEBiC)$153,612
U54 · FY2014 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$110,195
U54 · FY2014 · CA
Training Core$107,293
U54 · FY2014 · CA
Cancer Education Core: Curriculum in Cancer Medicine, Science, and Health Disparities$99,981
U54 · FY2014 · CA · contact PI
Planning and Evaluation Core$87,323
U54 · FY2014 · CA · contact PI
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$84,570
U54 · FY2014 · CA · contact PI
HPV Communication to Microenvironment via Exosomes$80,000
UH2 · FY2014 · TR
Education Core$67,588
U54 · FY2014 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$65,792
U54 · FY2014 · CA · contact PI
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$20,442
U54 · FY2014 · CA
Texas Center for Cancer Nanomedicine$1,850,049
U54 · FY2013 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$1,560,830
U54 · FY2013 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,077,820
U54 · FY2013 · CA · contact PI
Multistage Vectors (MSV) for Ovarian Cancer Therapeutics$572,549
U54 · FY2013 · CA · contact PI
Developmental Core$501,323
U54 · FY2013 · CA
Novel extra cellular RNA-based combinatorial RNA inhibition therapy$500,000
UH2 · FY2013 · TR
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)$307,162
U54 · FY2013 · CA
Outreach Core$286,379
U54 · FY2013 · CA
Administrative Core$261,422
U54 · FY2013 · CA
(PQD3) The role and therapeutic potential of ZNF304 in Ovarian Cancer$208,800
R21 · FY2013 · CA
Overall Objectives and ADM$206,229
U54 · FY2013 · CA · contact PI
Planning and Evaluation$171,812
U54 · FY2013 · CA
Biostatistics, Epidemiology, and Bioinformatics Core (BEBiC)$158,943
U54 · FY2013 · CA
Training Core$111,016
U54 · FY2013 · CA
Overall Review$99,429
U54 · FY2013 · CA · contact PI
Planning and Evaluation Core$85,414
U54 · FY2013 · CA · contact PI
Education Core$69,935
U54 · FY2013 · CA
Training Core$43,881
U54 · FY2013 · CA
Developmental Core$43,881
U54 · FY2013 · CA
Planning and Evaluation$43,881
U54 · FY2013 · CA
Administrative Core$43,881
U54 · FY2013 · CA
Education Core$43,880
U54 · FY2013 · CA
Outreach Core$43,879
U54 · FY2013 · CA
Biostatistics, Epidemiology, and Bioinformatics Core (BEBiC)$43,879
U54 · FY2013 · CA
Texas Center for Cancer Nanomedicine$2,538,514
U54 · FY2012 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$1,679,075
U54 · FY2012 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$1,206,053
U54 · FY2012 · CA
Multistage Vectors (MSV) for Ovarian Cancer Therapeutics$394,913
U54 · FY2012 · CA · contact PI
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$202,000
U54 · FY2012 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$74,686
U54 · FY2012 · CA
Planning and Evaluation Core$67,419
U54 · FY2012 · CA · contact PI
Texas Center for Cancer Nanomedicine$2,579,927
U54 · FY2011 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$1,494,018
U54 · FY2011 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$1,210,404
U54 · FY2011 · CA
Multistage Vectors (MSV) for Ovarian Cancer Therapeutics$674,633
U54 · FY2011 · CA · contact PI
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$201,528
U54 · FY2011 · CA
Planning and Evaluation Core$66,269
U54 · FY2011 · CA · contact PI
Texas Center for Cancer Nanomedicine$2,735,267
U54 · FY2010 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$1,543,594
U54 · FY2010 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$1,243,985
U54 · FY2010 · CA
Subcellular localization of nanoparticles$993,315
RC2 · FY2010 · GM
Multistage Vectors (MSV) for Ovarian Cancer Therapeutics$744,984
U54 · FY2010 · CA · contact PI
Subcellular localization of nanoparticles$495,098
RC2 · FY2010 · GM
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$225,768
U54 · FY2010 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$200,000
U54 · FY2010 · CA
Planning and Evaluation Core$70,365
U54 · FY2010 · CA · contact PI
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$1,664,784
U54 · FY2009 · CA
Subcellular localization of nanoparticles$1,513,417
RC2 · FY2009 · GM
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$1,119,031
U54 · FY2009 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$911,078
U54 · FY2009 · CA
Planning and Evaluation Core$70,795
U54 · FY2009 · CA · contact PI
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$1,584,860
U54 · FY2008 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research$1,216,467
U54 · FY2008 · CA
Planning and Evaluation Core$42,940
U54 · FY2008 · CA · contact PI
PRCC/MDACC: Partners for Excellence in Cancer Research$454,836
U54 · FY2007 · CA · contact PI
PRCC/MDACC: Partners for Excellence in Cancer Research$861,010
U54 · FY2006 · CA · contact PI
PRCC/MDACC: Partners for Excellence in Cancer Research$860,788
U54 · FY2005 · CA
PRCC/MDACC: Partners for Excellence in Cancer Research$836,194
U54 · FY2004 · CA
BIOIMMUNOTHERAPY TRAINING GRANT$118,475
T32 · FY2004 · CA
PRCC/MDACC: Partners for Excellence in Cancer Research$826,400
U54 · FY2003 · CA
PRCC/MDACC: Partners for Excellence in Cancer Research$793,835
U54 · FY2002 · CA
BIOIMMUNOTHERAPY TRAINING GRANT$223,262
T32 · FY2002 · CA
BIOIMMUNOTHERAPY TRAINING GRANT$55,739
T32 · FY2002 · CA
Molecular epidemiology of APL in Hispanic populations$0
U54 · FY2002 · CA
BIOIMMUNOTHERAPY TRAINING GRANT$135,370
T32 · FY2001 · CA
BIOIMMUNOTHERAPY TRAINING GRANT$71,098
T32 · FY2000 · CA